A detailed history of Freestone Capital Holdings, LLC transactions in Amgen Inc stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 13,187 shares of AMGN stock, worth $3.49 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
13,187
Previous 13,256 0.52%
Holding current value
$3.49 Million
Previous $4.14 Million 2.58%
% of portfolio
0.15%
Previous 0.15%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $21,347 - $23,279
-69 Reduced 0.52%
13,187 $4.25 Million
Q2 2024

Nov 22, 2024

BUY
$262.75 - $319.31 $151,606 - $184,241
577 Added 4.55%
13,256 $4.14 Million
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $151,606 - $184,241
577 Added 4.55%
13,256 $4.14 Million
Q1 2024

Nov 22, 2024

SELL
$268.87 - $324.56 $136,585 - $164,876
-508 Reduced 3.85%
12,679 $3.6 Million
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $26,080 - $31,482
-97 Reduced 0.76%
12,679 $3.6 Million
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $55,742 - $62,884
-218 Reduced 1.68%
12,776 $3.68 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $69,093 - $85,781
316 Added 2.49%
12,994 $3.49 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $177,201 - $209,536
-827 Reduced 6.12%
12,678 $2.81 Million
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $60,511 - $73,753
-268 Reduced 1.95%
13,505 $3.26 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $1.13 Million - $1.44 Million
-4,936 Reduced 26.38%
13,773 $3.62 Million
Q3 2022

Nov 09, 2022

SELL
$224.46 - $253.15 $1.32 Million - $1.49 Million
-5,893 Reduced 23.95%
18,709 $4.22 Million
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $1.45 Million - $1.61 Million
-6,272 Reduced 20.31%
24,602 $5.99 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $122,133 - $135,111
-557 Reduced 1.77%
30,874 $7.47 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $252,776 - $289,279
-1,271 Reduced 3.89%
31,431 $7.07 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $1.71 Million - $2.01 Million
-8,074 Reduced 19.8%
32,702 $6.95 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $4,671 - $5,182
20 Added 0.05%
40,776 $9.94 Million
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $940,232 - $1.1 Million
-4,237 Reduced 9.42%
40,756 $10.1 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $485,123 - $577,696
2,242 Added 5.24%
44,993 $10.3 Billion
Q3 2020

Nov 06, 2020

BUY
$234.65 - $260.95 $261,165 - $290,437
1,113 Added 2.67%
42,751 $10.9 Million
Q2 2020

Aug 04, 2020

BUY
$197.81 - $242.74 $231,833 - $284,491
1,172 Added 2.9%
41,638 $9.82 Million
Q1 2020

May 12, 2020

SELL
$182.24 - $241.7 $1.18 Million - $1.57 Million
-6,502 Reduced 13.84%
40,466 $8.2 Million
Q4 2019

Feb 04, 2020

BUY
$189.21 - $243.2 $1.49 Million - $1.92 Million
7,894 Added 20.2%
46,968 $11.3 Million
Q3 2019

Nov 07, 2019

BUY
$174.11 - $208.62 $8,531 - $10,222
49 Added 0.13%
39,074 $7.56 Million
Q2 2019

Aug 05, 2019

SELL
$166.7 - $195.41 $8.2 Million - $9.62 Million
-49,211 Reduced 55.77%
39,025 $7.19 Million
Q1 2019

May 08, 2019

SELL
$180.87 - $203.88 $4.82 Million - $5.43 Million
-26,640 Reduced 23.19%
88,236 $16.8 Million
Q4 2018

Feb 12, 2019

SELL
$178.4 - $208.25 $1.59 Million - $1.85 Million
-8,899 Reduced 7.19%
114,876 $22.4 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $15,564 - $17,546
-84 Reduced 0.07%
123,775 $25.7 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $12.8 Million - $14.4 Million
77,225 Added 165.6%
123,859 $22.9 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $1.61 Million - $1.88 Million
9,487 Added 25.54%
46,634 $7.95 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $654,398 - $731,163
3,877 Added 11.65%
37,147 $6.46 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $165,115 - $188,517
987 Added 3.06%
33,270 $6.2 Million
Q2 2017

Aug 15, 2017

BUY
N/A
32,283
32,283 $5.56 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.